BioSpace News Archive

BioMidwest

Selectively Targeting Cancerous T-Cells Using CAR-T Therapy

How can you selectively target and destroy cancerous T-cells using other T-cells? This question has plagued researches hoping to apply chimeric antigen receptor (CAR) T-cell therapies to T-cell cancers.

July 15, 2019
·
7 min read
·
Chelsea Weidman Burke, M.S.
Pharm Country

Botanix’s antimicrobial platform addresses significant global threat

New data has shown that a new drug candidate from Botanix’s cannabidiol antimicrobial platform has potent activity against hypervirulent strains of the bacteria Clostridium difficile

July 15, 2019
·
6 min read
Deals

Todos Medical Announces Launch of Public Offering

Todos Medical Ltd., a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer’s disease, announced that it has launched a roadshow for a public offering of up to $7,000,000 of units.

July 15, 2019
·
5 min read
Drug Development

GSK’s Zejula Hits the Mark in Phase III Ovarian Cancer Study, Could be Close to Naming New Chairman

According to reports, Novartis veteran Jonathan Symonds is likely to be named the next chairman of the board.

July 15, 2019
·
2 min read
·
Alex Keown
BioForest

AAIC: A Potential New Biomarker for Alzheimer’s Disease

One problem facing researchers in Alzheimer’s disease is the lack of really good diagnostic tests. Earlier this year, Bill Gates, Jeff Bezos and MacKenzie Bezos teamed to donate over $20 million to the Diagnostics Accelerator, part of the Alzheimer’s Drug Discovery Foundation (ADDF).

July 15, 2019
·
4 min read
·
Mark Terry
Drug Development

New Hope for Rare Mitochondrial Diseases: An Interview With Minovia Therapeutics’ Natalie Yivgi Ohana

In late June, Minovia Therapeutics dosed the first patient in a Phase I/II clinical trial with Pearson syndrome. The company is one of the first to make headway in treating rare mitochondrial diseases.

July 15, 2019
·
6 min read
·
Mark Terry
Business

MIT’s research enterprise in Singapore launches new research group, boosting nation’s cell therapies R&D

MIT’s Research Enterprise in Singapore, SMART, launches a new research group, Critical Analytics for Manufacturing Personalized-Medicine (CAMP), as part of Singapore’s National Cell Manufacturing Initiative to overcome scientific and technical challenges in life-changing cell therapies.

July 15, 2019
·
5 min read
Job Trends

New biomarker-guided strategy has potential for liver cancer treatment

Blocking IL-6 pathway may extend duration of immunotherapy and reduce side effects

July 15, 2019
·
4 min read
Business

Neon Therapeutics’ Cancer Vaccine Effective in Melanoma and Lung and Bladder Cancers

In all three cancer types, data showed prolonged and consistent improvements in progression-free survival (PFS) that is similar to that seen with checkpoint inhibitor monotherapy.

July 15, 2019
·
3 min read
·
Mark Terry
Policy

Purdue Pharma’s Sackler Family Being Torn Apart by Opioid Crisis Backlash

The Sackler family has earned billions from the sale of OxyContin and the backlash against the family has increased in-fighting, according to reports.

July 15, 2019
·
2 min read
·
Alex Keown